Dr. Reddy's Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: DRREDDY BSE: 500124

₹1203.00

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #8 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited (this stock)	100,411	150.9	10.9%	-3.7%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹105,493 Cr

EV / EBITDA

46.7x

EV / Sales

5.91x

Market cap / Sales

5.62x

Earnings yield

0.66%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 5,577 Cr, down 32.1% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 405 Cr, down 86.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	5,137	497	405	₹4.8600
March 31, 2026	3,822	-306	-219	₹-2.6300
Dec. 31, 2025	4,283	104	91	₹1.0900
Sept. 30, 2025	4,619	516	387	₹4.6500
June 30, 2025	7,810	3,936	2,961	₹35.5900
March 31, 2025	5,563	1,562	1,201	₹14.4100
Dec. 31, 2024	5,015	1,119	849	₹10.2000
Sept. 30, 2024	6,696	2,641	1,882	₹22.6000
June 30, 2024	5,841	1,914	1,417	₹85.1000
March 31, 2024	5,105	1,339	1,035	₹62.1400
Dec. 31, 2023	4,103	632	475	₹28.5500
Sept. 30, 2023	4,839	1,601	1,193	₹71.6800
June 30, 2023	5,437	2,220	1,639	₹98.6600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	5,577	4,389	4,643	4,983	8,208	5,977	5,250	6,904	6,059	5,318	4,331	5,062	5,671
Operating revenue	5,137	3,822	4,283	4,619	7,810	5,563	5,015	6,696	5,841	5,105	4,103	4,839	5,437
Other income	440	567	360	364	398	414	235	208	218	213	228	223	234
Operating expenses	4,689	4,322	4,183	4,138	3,972	4,120	3,823	3,975	3,888	3,726	3,447	3,210	3,210
Operating profit	447	-500	100	480	3,837	1,443	1,192	2,722	1,953	1,379	656	1,629	2,228
Operating profit margin	8.7%	-13.1%	2.3%	10.4%	49.1%	25.9%	23.8%	40.6%	33.4%	27.0%	16.0%	33.7%	41.0%
Depreciation	318	318	314	295	280	264	265	260	250	246	246	246	237
Interest	73	54	41	33	19	31	43	28	7	6	6	6	4
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	497	-306	104	516	3,936	1,562	1,119	2,641	1,914	1,339	632	1,601	2,220
Tax	92	-86	14	129	975	361	270	759	497	304	157	408	580
Net profit	405	—	91	387	2,961	1,201	849	1,882	1,417	1,035	475	1,193	1,639
EPS	4.86	-2.63	1.09	4.65	35.59	14.41	10.20	22.60	85.10	62.14	28.55	71.68	98.66
Net profit (TTM)	—	—	4,640	5,399	6,893	5,349	5,184	4,809	4,120	4,342	3,980	3,829	3,753
EPS (TTM)	7.97	38.70	55.74	64.85	82.80	132.31	180.04	198.39	247.47	261.03	239.38	230.37	225.94

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	20,533	4,251	3,220
March 31, 2025	23,115	7,236	5,349
March 31, 2024	19,484	5,791	4,342
March 31, 2023	16,962	3,866	2,613

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	8.0%	9.4%	22,223^†	24,191^†	20,381^†	17,650^†	14,887^†	14,165^†	12,595^†	10,901^†	9,569^†	10,302^†
Operating revenue	6.6%	9.0%	20,533	23,115	19,484	16,962	14,405^†	13,349^†	11,850^†	10,626^†	9,359^†	9,698^†
Other income	—	—	1,690^†	1,075^†	897^†	688^†	482^†	816^†	745^†	275^†	210^†	604^†
Operating expenses	—	—	16,616^†	15,805^†	13,592^†	12,844^†	11,811^†	10,227^†	8,982^†	8,363^†	8,035^†	—
Operating profit	-1.7%	4.6%	3,917^†	7,310^†	5,892^†	4,118^†	2,594^†	3,122^†	2,868^†	2,263^†	1,324^†	—
Operating profit margin	—	—	19.1%^†	31.6%^†	30.2%^†	24.3%^†	18.0%^†	23.4%^†	24.2%^†	21.3%^†	14.1%^†	—
Depreciation	—	—	1,207^†	1,039^†	976^†	923^†	814^†	835^†	789^†	781^†	774^†	—
Interest	—	—	148^†	110^†	22^†	17^†	38^†	47^†	48^†	57^†	63^†	57^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	3.2%	6.8%	4,251	7,236	5,791	3,866	2,224^†	3,056^†	2,776^†	1,701^†	697^†	1,544^†
Tax	—	—	1,032^†	1,886^†	1,449^†	1,253^†	601^†	870^†	-162^†	423^†	130^†	160^†
Net profit	7.2%	8.0%	3,220	5,349	4,342	2,613	1,623^†	2,186^†	2,938^†	1,277^†	567^†	1,384^†
EPS	-37.4%	-21.7%	38.70^†	132.31^†	261.03^†	157.38^†	97.85^†	131.83^†	177.23^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	19.1%^†	31.6%^†	30.2%^†	24.3%^†	18.0%^†	23.4%^†	24.2%^†	21.3%^†	14.1%^†	—
EBIT margin	21.4%^†	31.8%^†	29.8%^†	22.9%^†	15.7%^†	23.2%^†	23.8%^†	16.5%^†	8.1%^†	16.5%^†
PBT margin	20.7%	31.3%	29.7%	22.8%	15.4%^†	22.9%^†	23.4%^†	16.0%^†	7.4%^†	15.9%^†
Net margin	15.7%	23.1%	22.3%	15.4%	11.3%^†	16.4%^†	24.8%^†	12.0%^†	6.1%^†	14.3%^†
Interest coverage	29.67x^†	66.84x^†	266.66x^†	229.76x^†	59.52x^†	66.44x^†	59.07x^†	30.94x^†	12.12x^†	28.00x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.66x	1.91x	—	—	—	—	—	—	—	—
Quick ratio	1.22x	1.38x	—	—	—	—	—	—	—	—
Debt to equity	0.17x	0.12x	—	—	—	—	—	—	—	—
Return on equity	10.3%	18.5%	—	—	—	—	—	—	—	—
Return on assets	7.4%	14.0%	—	—	—	—	—	—	—	—
Return on capital employed	13.6%^†	24.8%^†	—	—	—	—	—	—	—	—
Asset turnover	0.47x	0.60x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	4,660	-5,785	1,117	2,049	2,611
March 31, 2025	4,225	-5,698	1,591	2,339	1,886
March 31, 2024	3,450	-3,430	68	1,361	2,089
March 31, 2023	5,053	-3,448	-2,697	1,000	4,053
March 31, 2022	1,339	-2,038	506	1,311	27

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	43,602	31,366	31,282	5,419	0	18,523	11,142	338	7,753	4,956
March 31, 2025	38,291	28,857	28,773	3,386	0	16,503	8,652	320	5,865	4,576
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.